These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 17993041

  • 1. Evaluation of the safety of modafinil for treatment of excessive sleepiness.
    Roth T, Schwartz JR, Hirshkowitz M, Erman MK, Dayno JM, Arora S.
    J Clin Sleep Med; 2007 Oct 15; 3(6):595-602. PubMed ID: 17993041
    [Abstract] [Full Text] [Related]

  • 2. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE, Hirshkowitz M.
    Sleep; 2005 Apr 15; 28(4):464-71. PubMed ID: 16171291
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y, Takasaki Y, Yamashiro Y.
    J Clin Sleep Med; 2013 Aug 15; 9(8):751-7. PubMed ID: 23946704
    [Abstract] [Full Text] [Related]

  • 4. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.
    Hirshkowitz M, Black J.
    CNS Drugs; 2007 Aug 15; 21(5):407-16. PubMed ID: 17447828
    [Abstract] [Full Text] [Related]

  • 5. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR, Khan A, McCall WV, Weintraub J, Tiller J.
    J Clin Sleep Med; 2010 Oct 15; 6(5):450-7. PubMed ID: 20957845
    [Abstract] [Full Text] [Related]

  • 6. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):552-9. PubMed ID: 18053628
    [Abstract] [Full Text] [Related]

  • 7. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T, Rippon GA, Arora S.
    Sleep Breath; 2008 Mar 15; 12(1):53-62. PubMed ID: 17874255
    [Abstract] [Full Text] [Related]

  • 8. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May 15; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 9. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE, Hull SG, Tiller J, Yang R, Harsh JR.
    J Clin Sleep Med; 2010 Oct 15; 6(5):458-66. PubMed ID: 20957846
    [Abstract] [Full Text] [Related]

  • 10. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ, Liu K, Hutzelmann J, Snavely D, Snyder E, Ceesay P, Lines C, Michelson D, Roth T.
    Sleep Med; 2013 Oct 15; 14(10):955-63. PubMed ID: 23920422
    [Abstract] [Full Text] [Related]

  • 11. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul 15; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]

  • 12. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
    Schwartz JR, Hirshkowitz M, Erman MK, Schmidt-Nowara W.
    Chest; 2003 Dec 15; 124(6):2192-9. PubMed ID: 14665500
    [Abstract] [Full Text] [Related]

  • 13. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.
    Pack AI, Black JE, Schwartz JR, Matheson JK.
    Am J Respir Crit Care Med; 2001 Nov 01; 164(9):1675-81. PubMed ID: 11719309
    [Abstract] [Full Text] [Related]

  • 14. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y, Miki M, Tabata T.
    Sleep Med; 2016 Nov 01; 27-28():45-48. PubMed ID: 27938918
    [Abstract] [Full Text] [Related]

  • 15. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.
    Keating GM, Raffin MJ.
    CNS Drugs; 2005 Nov 01; 19(9):785-803. PubMed ID: 16142993
    [Abstract] [Full Text] [Related]

  • 16. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis.
    Chapman JL, Vakulin A, Hedner J, Yee BJ, Marshall NS.
    Eur Respir J; 2016 May 01; 47(5):1420-8. PubMed ID: 26846828
    [Abstract] [Full Text] [Related]

  • 17. Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment.
    Weaver TE, Chasens ER, Arora S.
    J Clin Sleep Med; 2009 Dec 15; 5(6):499-505. PubMed ID: 20465014
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD, Harsh JR, Yang R, Rippon GA, Lankford DA.
    J Clin Psychiatry; 2010 Jan 15; 71(1):32-40. PubMed ID: 20051221
    [Abstract] [Full Text] [Related]

  • 19. Modafinil: new indications for wake promotion.
    Schwartz JR.
    Expert Opin Pharmacother; 2005 Jan 15; 6(1):115-29. PubMed ID: 15709889
    [Abstract] [Full Text] [Related]

  • 20. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.
    Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF.
    Neurology; 1997 Aug 15; 49(2):444-51. PubMed ID: 9270575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.